Anti‐Allergic Potential of Chamaecrista nomame and Its Compound Luteolin for Novel Asthma Therapy
Tae Kyeom Kang, Myungsuk Kim, Tam Thi Le, Geon Park, Yuna Jung, Hyobin Jeong, Youngsang Yoo, Wook‐Bin Lee, Sang Hoon Jung · 2026
Read Anti‐Allergic Potential of Chamaecrista nomame and Its Compound Luteolin for Novel Asthma Therapy by Tae Kyeom Kang, Myungsuk Kim, Tam Thi Le, Geon Park, Yuna Jung, Hyobin Jeong, Youngsang Yoo, Wook‐Bin Lee, Sang Hoon Jung (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13340961.txt.
Description
Tae Kyeom Kang and co-authors test a plant extract and its active compound against allergic asthma in this 2026 study. Asthma is a long-term swelling disease driven by immune overreaction and mast cell firing. Steroids are the main treatment, but long use brings side effects. The plant, Chamaecrista nomame, was split into parts to find the active ones. A compound called luteolin stood out in that search. A mouse model of asthma, triggered by egg protein, tested the extract.
Gene activity in mast cells was mapped to find luteolin's pathways. Mast cells are early triggers in allergic attacks. If the compound calms them, it could ease the whole chain. The authors aim at a safer, plant-based therapy path. Mouse and cell results form the evidence at this stage. Human testing would come only after more safety work.
Catalog record
| CREATOR | Tae Kyeom Kang, Myungsuk Kim, Tam Thi Le, Geon Park, Yuna Jung, Hyobin Jeong, Youngsang Yoo, Wook‐Bin Lee, Sang Hoon Jung |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |